Panacea Biotech-A high risk, huge reward stock!Panacea biotech is in news for developing Dengue vaccine.
Technically, stock has bounced from support trendline and is looking strong to test ATH levels once again which can be around 2x from CMP.
Keep in watchlist. A very risky volatile stock and is not a recommendation.
PANACEABIO
PANACEABIO - BO on new ordersPANACEABIO is trading in the range for the past couple of months and breakout by 18% today with huge volumes.
The reason for this is due to " $127.3 million orders from UNICEF and PAHO for the supply of its WHO pre-qualified fully liquid Pentavalent vaccine"
With this movement, Trend Ch +ve.
Close Crossing 4-week High
Crossed Monthly Pivot upside
Close is above Daily and Weekly SMA 20. But below Monthly 20 SMA.
The weekly trend changed to +ve. Still, the monthly trend is on the -ve side.
Daily SMA 13 Crossed SMA 55 upside.
Weekly SMA 13<34<55, But Close crossed Weekly SMA 13 Upside
RSI- M:46.0 WK:55.4 D:75.0
Add to the watchlist - take your own decision.